Creatine kinase (CK) and lactate dehydrogenase (LDH) are widely used markers of tissue damage. To search for sequence variants influencing serum levels of CK and LDH, 28.3 million sequence variants identified through whole-genome sequencing of 2,636 Icelanders were imputed into 63,159 and 98,585 people with CK and LDH measurements, respectively. Here we describe 13 variants associating with serum CK and 16 with LDH levels, including four that associate with both. Among those, 15 are non-synonymous variants and 12 have a minor allele frequency below 5%. We report sequence variants in genes encoding the enzymes being measured (CKM and LDHA), as well as in genes linked to muscular (ANO5) and immune/inflammatory function (CD163/CD163L1, CSF1, CFH, HLA-DQB1, LILRB5, NINJ1 and STAB1). A number of the genes are linked to the mononuclear/phagocyte system and clearance of enzymes from the serum. This highlights the variety in the sources of normal diversity in serum levels of enzymes.
Notes
Cites: Immunol Rev. 2008 Aug;224:98-12318759923
Cites: Mayo Clin Proc. 2008 Jun;83(6):687-70018533086
Cites: J Immunol. 2008 Dec 15;181(12):8433-4019050261
Cites: Bioinformatics. 2008 Dec 15;24(24):2938-918974171
Cites: Nat Genet. 2008 Sep;40(9):1068-7519165921
Cites: N Engl J Med. 2009 Jul 2;361(1):62-7219571284
Cites: Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2037-4220133848